A Study to Assess Intraocular Pressure and Ocular Safety of the Beta-3 Agonist Mirabegron in Research Subjects

NCT01284309 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

321

Enrollment

INDUSTRY

Sponsor class

Conditions

Intraocular Pressure

Interventions

DRUG: Mirabegron
DRUG: Placebo

Sponsor

Astellas Pharma Inc